Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / 종양 대상 Immunomodulation에 대 한 paramyxoviruses: 설계 및 …
JoVE Journal
Cancer Research

A subscription to JoVE is required to view this content.

JoVE Journal Cancer Research
종양 대상 Immunomodulation에 대 한 paramyxoviruses
Capturing Small Molecule Communication Between Tissues and Cells Using Imaging Mass Spectrometry
Journal (Cancer Research)
Capturing Small Molecule Communication Between Tissues and Cells Using Imaging Mass Spectrometry
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Journal (Cancer Research)
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
 
Click here for the English version

종양 대상 Immunomodulation에 대 한 paramyxoviruses: 설계 및 평가 전 비보

Article DOI: 10.3791/58651-v • 12:42 min • January 7th, 2019
January 7th, 2019 •
1,2, 1,3
1Department of Translational Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 2Faculty of Biosciences, Heidelberg University, 3Department of Medical Oncology, NCT and Heidelberg University Hospital

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

이 프로토콜 설명 합니다 자세한 워크플로 생성에 대 한 immunomodulators, 예를 들어 bispecific T 세포 engagers를 인코딩 하는 홍 역 바이러스를 사용 하 여 표현 위한 oncolytic 바이러스의 비보 특성화 전. 응용 프로그램 및 다른 벡터 플랫폼 및 transgenes 적응 임상 번역 소설 immunovirotherapeutics의 개발을 가속화할 것 이다.

Tags

암 연구 문제점 143 Oncolytic virotherapy 암 immunotherapy 바이러스 성 벡터 홍 역 바이러스 바이러스인 bispecific T 셀 engager
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter